Publications

Export 9 results:
Sort by: Author [ Title  (Asc)] Type Year
A B C D E F G H [I] J K L M N O P Q R S T U V W X Y Z   [Show ALL]
I
Ragab, G., M. A. El-Ghobary, R. M. Elgohary, and others, "The importance of using ultrasonography in knee osteoarthritis", The Egyptian Journal of Internal Medicine, vol. 24, no. 3: Medknow Publications, pp. 93, 2012. Abstract
n/a
Ragab, G., M. A. El-Ghobary, and R. M. Elgohary, "The importance of using ultrasonography in knee osteoarthritis", The Egyptian Journal of Internal Medicine, vol. 24, issue 3: SpringerOpen, pp. 93-96, 2012. Abstract
n/a
Hegazy, M. T., W. R. Allam, M. A. Hussein, N. Zoheir, L. Quartuccio, S. F. El-Khamisy, and G. Ragab, "Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs", EBioMedicine, vol. 35: Elsevier, pp. 106-113, 2018. Abstract
n/a
Hegazy, M. T., W. R. Allam, M. A. Hussein, N. Zoheir, L. Quartuccio, S. F. El-Khamisy, G. Ragab, and M. C. C. the for the study of Vasculitis, "Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs", EBioMedicine, vol. 35: Elsevier B.V., pp. 106 - 113, 2018. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Hegazy, M. T., W. R. Allam, M. A. Hussein, N. Zoheir, L. Quartuccio, S. F. El-Khamisy, and G. Ragab, "Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs.", EBioMedicine, vol. 35, pp. 106-113, 2018 Sep. Abstract

Mixed Cryoglobulinemic Vasculitis (MCV) is a prominent extra-hepatic manifestation of Hepatitis C virus (HCV) infection. HCV has been reported to cause B-cell disorders and genomic instability. Here, we investigated B-cell activation and genome stability in HCV-MCV patients receiving the direct antiviral agent, Sofosbuvir, at multiple centers in Egypt. Clinical manifestations in HCV-MCV patients were improved at the end of treatment (EOT), such as purpura (100%), articular manifestations (75%) and neuropathy (68%). Eighteen patients (56%) showed vasculitis relapse after EOT. BAFF and APRIL were higher at EOT and continued to increase one year following treatment onset. Chromosomal breaks were elevated at EOT compared to baseline levels and were sustained at 3 and 6 months post treatment. We report increased expression of DNA genome stability transcripts such as topoisomerase 1 and TDP1 in HCV-MCV patients after treatment, which continued to increase at 12 months from treatment onset. This data suggest that B-cell activation and DNA damage are important determinants of HCV-MCV treatment outcomes.

Ferri, C., M. Ramos-Casals, A. L. Zignego, L. Arcaini, D. Roccatello, A. Antonelli, D. Saadoun, A. C. Desbois, M. Sebastiani, and M. Casato, "International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement", Autoimmunity Reviews, vol. 15, issue 12: Elsevier, pp. 1145-1160, 2016. Abstract
n/a
Hamza, M. M. E., T. A. Macky, M. K. Sidky, G. Ragab, and M. M. Soliman, "Intravitreal infliximab in refractory uveitis in Behçet's disease: a safety and efficacy clinical study", Retina, vol. 36, issue 12: LWW, pp. 2399-2408, 2016. Abstract
n/a
Hamza, M. M. E., T. A. Macky, M. K. Sidky, G. Ragab, and M. M. Soliman, "Intravitreal infliximab in refractory uveitis in Behcet's disease: A safety and efficacy clinical study", Retina, vol. 36, issue 12: Lippincott Williams and Wilkins, pp. 2399 - 2408, 2016. Abstracthttps://scholar.google.com.eg/citations?hl=en&user=7L5p7RYAAAAJ
n/a
Tourism